IPOs
– Galmed Pharmaceuticals Ltd., a clinical-stage biotech developing therapies for liver diseases and gallstones, filed on Thursday with the SEC to raise up to $35...
Hi, what are you looking for?
– Galmed Pharmaceuticals Ltd., a clinical-stage biotech developing therapies for liver diseases and gallstones, filed on Thursday with the SEC to raise up to $35...
– The company will issue 14 million shares at $2.40 per share, a ten-year low. – CEO Ira Palati – Ceragon Networks Ltd. (NASDAQ:...
– The surgical systems company has filed with the US Securities and Exchange Commission (SEC) a prospectus to issue two million American Depository. –...